CDH1 and breast cancer: As compared to SN of the previously investigated genes (APC, CDH1, P14 and P16), our findings were notably lower due to the nature of our study participants with exclusion of patients under BC surveillance and lesser patients with ≥T2/HG disease as these tumors probably harbor more molecular alterations [26].